Cargando…
Medical Management of Drug-Resistant Tuberculosis
Drug-resistant tuberculosis (TB) is still a major threat worldwide. However, recent scientific advances in diagnostic and therapeutic tools have improved the management of drug-resistant TB. The development of rapid molecular testing methods allows for the early detection of drug resistance and prom...
Autor principal: | Jeon, Doosoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499582/ https://www.ncbi.nlm.nih.gov/pubmed/26175768 http://dx.doi.org/10.4046/trd.2015.78.3.168 |
Ejemplares similares
-
WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea
por: Jeon, Doosoo
Publicado: (2017) -
Latent tuberculosis infection: recent progress and challenges in South Korea
por: Jeon, Doosoo
Publicado: (2020) -
Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation
por: Jeon, Doosoo, et al.
Publicado: (2020) -
Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design
por: Mok, Jeong Ha, et al.
Publicado: (2017) -
Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019
por: Lee, Taehoon, et al.
Publicado: (2021)